Visit our Re-post guidelines
"Genistein is, by far, the most studied soy isoflavone in this regard, and it has been shown to inhibit the infectivity of enveloped or nonenveloped viruses, as well as single-stranded or double-stranded RNA or DNA viruses. At concentrations ranging from physiological to supraphysiological (3.7-370 muM), flavonoids, including genistein, have been shown to reduce the infectivity of a variety of viruses affecting humans and animals, including adenovirus, herpes simplex virus, human immunodeficiency virus, porcine reproductive and respiratory syndrome virus, and rotavirus."
What are Other Potential Natural Therapeutics for Ebola?
First, it must be pointed out that, historically, Ebola virus outbreaks occur in some of the most impoverished places on Earth (primarily the poorest regions of Africa), among populations chronically malnourished, traumatized by sociopolitical unrest and wars, and where modern day sanitation, hygiene practices, and adequate nutrition, are available suboptimally, to say the least. In other words, the mainstream media's prediction of a so-called 'catastrophic' outbreak in the US and other wealthier countries does not seem to take into account the differing contexts that makes infections like these possible to begin with, with the 'inner terrain,' i.e. immune status of the host, fundamental in determining the degree to which an individual becomes susceptible to infection.
With that said, Ebola does appear to be a uniquely pathogenic virus to which the human body has yet had adequate time to properly adapt, and therefore it is instructive to point other potential natural therapies that have been studied in the past:
- Garcinia kola: As reported in 1999, extracts from the seeds of this traditional African medicinal herb were found to"...inhibit this virus [Ebola] in cell culture at non-toxic concentrations."
- Vitamin C: According to the late Dr Robert Cathcart, MD, who had extensive experience treating deadly infections with high dose vitamin C, "the Ebola virus kills by way of free radicals which can be neutralized by massive doses of sodium ascorbate intravenously." Indeed, Ebola virus disease -- as is the case with viral hemorrhagic disease in general -- resembles features of acute scurvy, and vitamin C is well known to have a broad range of benefits, including immune-boosting and antiviral properties, with an incredibly high safety margin.
- Homeopathic interventions: A study published in 1999 explored the therapeutic potential of a homeopathic preparation of the six-eyed spider venom (Sicarius) at treating symptoms associated with Ebolavirus infection.
- Estradiol: A 2013 analysis, titled "A systematic screen of FDA-approved drugs for inhibitors of biological threat agents," found that estradiol exhibited anti-Ebola virus activity in vitro, indicating the relevance of hormonal factors and perhaps gender in susceptibility to the disease – as well as a possible therapeutic role for estradiol if future clinical research confirms bears these findings out.
This is only a small sampling, and the fact is that very little research has been performed in this area. There are a wide range of natural compounds that have yet to be evaluated for their direct anti-Ebola activity and/or immune boosting properties, and that may be highly relevant to the goal of preventing and curing it. The most important consideration is that no infection – including highly lethal ones like Ebola – occurs in a vacuum. Psychological, biological, environmental and sociopolitical factors all determine the incidence, spread and virulence of viral infections. Therefore, in the absence of any known drug- or vaccine-based method to prevent or reduce harm from Ebola infection, the aforementioned research and 'environmental' considerations may provide future hope and direction for addressing epidemics of this kind. This is especially important considering how profoundly fearful folks have become at the specter of diseases they do not understand -- fears which contribute to immunosuppression and therefore may contribute to the self-fulfilling prophecy associated with belief in Ebola's extreme lethality.
 Isaacson, M; Sureau, P; Courteille, G; Pattyn, SR;. Clinical Aspects of Ebola Virus Disease at the Ngaliema Hospital, Kinshasa, Zaire, 1976. Retrieved 2009-07-08.
 Kuhn, J. H.; Becker, S.; Ebihara, H.; Geisbert, T. W.; Johnson, K. M.; Kawaoka, Y.; Lipkin, W. I.; Negredo, A. I.; Netesov, S. V.; Nichol, S. T.; Palacios, G.; Peters, C. J.; Tenorio, A.; Volchkov, V. E.; Jahrling, P. B. (2010). "Proposal for a revised taxonomy of the family Filoviridae: Classification, names of taxa and viruses, and virus abbreviations". Archives of Virology 155 (12): 2083–2103. doi:10.1007/s00705-010-0814-x. PMC 3074192. PMID 21046175.
 Aline Andres, Sharon M Donovan, Mark S Kuhlenschmidt. Soy isoflavones and virus infections. J Nutr Biochem. 2009 Aug;20(8):563-9. PMID: 19596314